In addition to altering practice habits to better align with national guidelines we also hoped to demonstrate positive downstream effects of a lower corticosteroid dose measured by length of stay following hospital admission, 30-day hospital readmission, mortality, and total hospital insulin dosing (used as an indirect measure of hyperglycemia). This evidence concerns the gene INS and Hyperglycemia.